Novavax Announces Initiation of COVID-19 Vaccine Booster Study in Adolescents in Phase 3 PREVENT-19 TrialPRNewsWire • 04/22/22
Novavax: Management's Revenue Guidance - If It Can Be Trusted - Makes The Bull CaseSeeking Alpha • 04/21/22
Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination VaccinePRNewsWire • 04/20/22
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in JapanPRNewsWire • 04/19/22
Novavax Grows Presence at World Vaccine Congress and 32nd European Congress of Clinical Microbiology & Infectious DiseasesPRNewsWire • 04/18/22